Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline
- PMID: 34461208
- DOI: 10.1016/j.jhep.2021.08.017
Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline
Keywords: FIB-4; chronic liver disease; epidemiology; fibrosis; liver stiffness; non-invasive tests.
Conflict of interest statement
Conflict of interest MS has received speaker's fees and research support from Fujirebio and received grants from Gilead. RdK is a speaker for Echosens, consultant for AbbVie and received grants from Abbvie, Gilead and Janssen. The remaining authors reported no relevant conflicts. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update".J Hepatol. 2022 Jan;76(1):251-252. doi: 10.1016/j.jhep.2021.10.008. Epub 2021 Nov 4. J Hepatol. 2022. PMID: 34742599 No abstract available.
Comment on
-
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.J Hepatol. 2021 Sep;75(3):659-689. doi: 10.1016/j.jhep.2021.05.025. Epub 2021 Jun 21. J Hepatol. 2021. PMID: 34166721
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
